Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.
Authors: Ando F; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Kashiwada T; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Kuroda S; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan., Fujii T; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Takano R; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Miyabe Y; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Immunology and Parasitology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan., Kunugi S; Department of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan., Sakatani T; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Miyanaga A; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Asatsuma-Okumura T; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan., Hashiguchi M; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan., Kanazawa Y; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Ohashi R; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Yoshida H; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Seike M; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Gemma A; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Iwai Y; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.
Source: Frontiers in pharmacology [Front Pharmacol] 2024 May 07; Vol. 15, pp. 1384731. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first